Canada Pension Plan Investment Board Purchases 93,100 Shares of Teladoc Health, Inc. $TDOC

Key Points

• The Canada Pension Plan Investment Board increased its holdings in Teladoc Health by 40.7% in Q1, owning 321,800 shares worth approximately $2.56 million.
• Analysts have lowered price targets for Teladoc Health, with Wells Fargo setting it at $8.00 and Bank of America at $7.00, while the average target is currently $9.80.
• Teladoc Health reported a quarterly earnings of ($0.19) EPS, surpassing expectations, despite a 1.6% year-over-year decline in revenue at $631.90 million.

Canada Pension Plan Investment Board increased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 40.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 321,800 shares of the health services provider's stock after purchasing an additional 93,100 shares during the period. Canada Pension Plan Investment Board owned approximately 0.18% of Teladoc Health worth $2,562,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD increased its holdings in Teladoc Health by 13.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 138,687 shares of the health services provider's stock valued at $1,261,000 after buying an additional 15,953 shares during the last quarter. Northern Trust Corp increased its stake in shares of Teladoc Health by 10.7% in the fourth quarter. Northern Trust Corp now owns 1,679,382 shares of the health services provider's stock worth $15,266,000 after purchasing an additional 161,875 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its stake in shares of Teladoc Health by 9.6% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock worth $113,000 after purchasing an additional 1,089 shares in the last quarter. Algert Global LLC purchased a new stake in shares of Teladoc Health in the fourth quarter worth $313,000. Finally, Bayesian Capital Management LP purchased a new stake in shares of Teladoc Health in the fourth quarter worth $170,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Trading Up 2.5%

TDOC stock traded up $0.19 during trading on Friday, hitting $7.82. The company had a trading volume of 4,939,073 shares, compared to its average volume of 4,947,288. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $1.38 billion, a P/E ratio of -6.57 and a beta of 1.84. The company has a 50 day simple moving average of $7.78 and a 200-day simple moving average of $7.82. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The company's revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, research analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

TDOC has been the subject of a number of research reports. Bank of America dropped their target price on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th. Evercore ISI raised their target price on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Truist Financial lowered their target price on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a report on Tuesday, May 27th. Finally, Mizuho assumed coverage on shares of Teladoc Health in a report on Friday, July 25th. They issued a "neutral" rating and a $10.00 target price for the company. Six investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, Teladoc Health has an average rating of "Hold" and a consensus target price of $9.80.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.